Literature DB >> 18638706

Why some injection drug users lick their needles: a preliminary survey.

Meredith Deutscher1, David C Perlman.   

Abstract

BACKGROUND: Injection drug users (IDUs) with poor hygiene practices are at risk for infection with their commensal flora. One example of a poor hygiene practice is licking the needle prior to injecting the drug. There are few published reports addressing the proportion of IDUs who lick their needles prior to injection and no prior studies evaluating the reasons for this practice.
METHODS: We conducted face-to-face interviews with 40 IDUs admitted to the internal medicine service at our institution. We collected data regarding whether the subject licked the needle before injecting drugs, whether the subject licked the injection site before or after injecting drugs, and the reasons they report for doing so.
RESULTS: Thirteen (32.5%, 95% CI, 18.6-49.1) of 40 subjects reported licking their needles prior to injecting. Reasons included ritualistic practices, cleaning the needle, enjoying the taste of the drug, checking the "quality" of the drug, and checking that the needle was in usable condition.
CONCLUSIONS: In our study, approximately one-third of IDUs licked their needles prior to injecting. More data are needed to demonstrate whether the practice of needle licking significantly increases a person's risk for infection with oropharyngeal flora. Medical providers should ask patients about specific practices surrounding injection drug use, and educate drug users about avoiding unhygienic injection practices.

Entities:  

Mesh:

Year:  2007        PMID: 18638706     DOI: 10.1016/j.drugpo.2007.06.006

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  12 in total

1.  Clinical Significance and Characterization of Streptococcus tigurinus Isolates in an Adult Population.

Authors:  Lori Bourassa; J E Clarridge
Journal:  J Clin Microbiol       Date:  2015-09-09       Impact factor: 5.948

2.  Injection Drug Users' Perceived Barriers to Using Self-Initiated Harm Reduction Strategies.

Authors:  Erin E Bonar; Harold Rosenberg
Journal:  Addict Res Theory       Date:  2014-08-01

3.  Opiate Injection-associated Infective Endocarditis in the Southeastern United States.

Authors:  Lauren Hartman; Erin Barnes; Laura Bachmann; Katherine Schafer; James Lovato; Daniel Clark Files
Journal:  Am J Med Sci       Date:  2016-08-23       Impact factor: 2.378

4.  Solobacterium moorei bacteremia: identification, antimicrobial susceptibility, and clinical characteristics.

Authors:  Rune Micha Pedersen; Hanne Marie Holt; Ulrik Stenz Justesen
Journal:  J Clin Microbiol       Date:  2011-04-27       Impact factor: 5.948

5.  Injection Drug Use-Associated Candidemia: Incidence, Clinical Features, and Outcomes, East Tennessee, 2014-2018.

Authors:  John A Rossow; Radhika Gharpure; Julia Brennan; Pryanka Relan; Sabrina R Williams; Snigdha Vallabhaneni; Brendan R Jackson; Caroline R Graber; Sherry R Hillis; William Schaffner; John R Dunn; Timothy F Jones
Journal:  J Infect Dis       Date:  2020-09-02       Impact factor: 5.226

6.  Risk Factors Associated With Skin and Soft Tissue Infections Among Hospitalized People Who Inject Drugs.

Authors:  Kristina T Phillips; Bradley J Anderson; Debra S Herman; Jane M Liebschutz; Michael D Stein
Journal:  J Addict Med       Date:  2017 Nov/Dec       Impact factor: 3.702

7.  Relapse of polymicrobial endocarditis in an intravenous drug user.

Authors:  Ruth W Wang'ondu; Thomas S Murray
Journal:  Yale J Biol Med       Date:  2011-09

8.  Novel Routes of Potential Hepatitis C Virus Transmission among People Who Inject Drugs: Secondary Blood Exposures Related to Injection Drug Use.

Authors:  Jesse L Goldshear; Kelsey A Simpson; Alex H Kral; Lynn D Wenger; Ricky N Bluthenthal
Journal:  Subst Use Misuse       Date:  2021-03-26       Impact factor: 2.362

9.  Subcutaneous Eikenella corrodens, Actinomyces sp., and α-Hemolytic Streptococcus Abscess of the Thigh following a Vitamin B12 Injection.

Authors:  Micheal G Adondakis; John G Skedros; Bert K Lopansri; Stephen C Merrell
Journal:  Case Rep Infect Dis       Date:  2018-04-11

10.  Efficacy and Safety of Tedizolid and Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Injection Drug Users: Analysis of Two Clinical Trials.

Authors:  Gregory J Moran; Carisa De Anda; Anita F Das; Sinikka Green; Purvi Mehra; Philippe Prokocimer
Journal:  Infect Dis Ther       Date:  2018-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.